🇺🇸 Xiao-Yao-San in United States

3 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 3

Most-reported reactions

1. Drug Ineffective — 1 report (33.33%)
2. Injection Site Swelling — 1 report (33.33%)
3. Migraine — 1 report (33.33%)

Source database →

Frequently asked questions

Is Xiao-Yao-San approved in United States?

Xiao-Yao-San does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Xiao-Yao-San in United States?

Yu-Ching HSU is the originator. The local marketing authorisation holder may differ — check the official source linked above.